XBiotech Inc.XBITNASDAQ

52-Week Range2-4

2.09Current 2.383.62

Want to monitor XBIT?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

xbiotech is developing a first-in-class monoclonal antibody (mabp1) to inhibit chronic inflammation.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Oracle Pushes Up Capex Spending on AI: High Risk or High Reward?

Darden Q3 Earnings Meet Estimates, Revenues Top, Both Rise Y/Y

Buy The Dip: Best Stocks With Forward EPS Growth Above 40%

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

Papa John's Partners Deliverect: Can Delivery Tech Drive Growth?

Micron Stock Slips Despite Blowout Earnings, Upbeat Guidance

Is it too late to invest in Cheniere stock as it hits all-time high?

Barrack, Rodos & Bacine Notifies Shareholders of Gemini Space Station Inc. (GEMI) of a Securities Class Action Lawsuit

Innovative Industrial Properties: Attractive Business, But High Oil Prices Could Be A Problem

Darden Restaurants: Solid Q3, But Risks Are Building

Why PROG Holdings (PRG) is a Great Dividend Stock Right Now

Why Toronto-Dominion Bank (TD) is a Great Dividend Stock Right Now

Goldman Sachs (GS) is a Top Dividend Stock Right Now: Should You Buy?

Why Union Pacific (UNP) is a Great Dividend Stock Right Now

Wells Fargo (WFC) Could Be a Great Choice

Micron stock slips 5% after earnings: should you buy the dip?

Red Cat Holdings: No Formal Guidance, Big Selloff - I Loaded The Truck

Lenzing Aktiengesellschaft (LNZNF) Q4 2025 Earnings Call Transcript

Accenture plc (ACN) Q2 2026 Earnings Call Transcript

About